• About
    Mission and HistoryExpertsIndependence and TransparencyInternships/Research Fellows
  • Explore Our WorkExplore Our Work
    • Our Work
      • Work
        • Amicus Briefs
        • Diversity and Inclusion
        • Economic & Policy Analysis
        • Fair Fight Film
        • Grant Research
        • Legal Analysis
        • Podcasts
        • Public Comments and Testimony
        • Reports
      • Issues By Sector
        • Airlines
        • Banking & Finance
        • Digital Technology
        • Energy
        • Food & Agriculture
        • Health & Pharmaceuticals
        • Innovation & Entrepreneurship
        • Intellectual Property
        • International
        • Labor
        • Media & Communications
        • Retail & Distribution
        • Transportation
      • Issues By Enforcement Area
        • Buyer Power
        • Cartels
        • Collusion
        • Exemptions & Immunities
        • Mergers
        • Monopolies
        • Private Enforcement
        • Public Enforcement
  • Events
  • Awards
    Alfred E. Kahn Award for Antitrust AchievementAntitrust Enforcement AwardsPrivate Antitrust Enforcement Hall of FameHollis Salzman Memorial Leadership AwardJerry S. Cohen Award for Antitrust Scholarship (administered by Cohen Milstein and hosted by AAI)
  • CLE Programs
  • Support
    Supporting AAIDonateSponsorshipsCy PresGrants

Archives: Work Products

Amicus Briefs

AAI Asks Second Circuit for Clear Thinking When Pharmaceutical Markets Are Monopolized by Patent Fraud (Regeneron v. Novartis)

June 20, 2022 | Randy Stutz
Exclusionary Conduct , Intellectual Property , Monopolies , Health & Pharmaceuticals
Reports

AAI Report Examines FTC’s Pharmaceutical Merger Policy in Light of Mounting Antitrust Violations, Calls for Overhaul of Commission’s Approach of Approving Mergers Subject to Divestitures

June 14, 2022 | Diana L. Moss
Health & Pharmaceuticals , FTC , Mergers
Podcasts

From Medical Licensing to Health Insurance: Major Policy Issues That Will Shape the Future of Telehealth

June 13, 2022 | Diana L. Moss, Kim Horvath, Jenna Milaeger
Competition Policy , Health & Pharmaceuticals , Innovation
Economic & Policy Analysis

AAI President and Advisors to Speak at June 14-15 Federal Trade Commission/U.S. Dept. of Justice Workshop on Enforcing the Antitrust Laws in the Pharmaceutical Industry

June 9, 2022 | Diana L. Moss
Public Enforcement , Health & Pharmaceuticals , Private Enforcement , Collusion
Podcasts

The High Costs of Growing Corn: How Growers are Squeezed by High Input Prices That Are Set by the Fertilizer Oligopoly

May 24, 2022 | Diana L. Moss, Dee Vaughan, Dr. Joe Outlaw
Food & Agriculture , Collusion , International
Economic & Policy Analysis

Antitrust Experts Review New Data on Private U.S. Antitrust Enforcement, Identify COVID-19 Implications and Key Statistical Trends

May 24, 2022 | Laura Alexander, Joshua P. Davis, Diana L. Moss, Randy Stutz
Competition Policy , Private Enforcement
Public Comments and Testimony

AAI Paper Calls for Careful Analysis of Apple’s Security Justifications for App Store Restrictions to Avoid False Negatives

May 24, 2022 | Randy Stutz
Competition Policy , Exclusionary Conduct , Technology , Section 2 of the Sherman Act , Monopolies
Public Comments and Testimony

AAI Asks USDA to Weigh in on Agricultural Biotechnology, Says Growers and Consumers Feel the Effects of Harmful Mergers

May 17, 2022
Competition Policy , Food & Agriculture , Innovation , Mergers
Economic & Policy Analysis

AAI Highlights New Multidisciplinary Analysis of Price Maintenance in the U.S., EU, and China

May 10, 2022 | Diana L. Moss, Riley T. Krotz, Gregory T. Gundlach
Competition Policy , RPM , Vertical Restraints , Section 1 of the Sherman Act
Podcasts

Litigation Funding Is Changing the Contours of Antitrust Class Actions in the U.S. and Abroad

May 4, 2022 | Laura Alexander, William A. Isaacson, Dai Wai Chin Feman
Private Enforcement , Banking & Finance

Posts navigation

Older posts

Support AAI

Promoting competition that protects consumers, businesses, and society is more important than ever. Through our research, education, and advocacy programs, AAI has been active in focusing public and private competition enforcement priorities and shaping progressive competition policy. The only way for AAI to fulfill its mission is through your support.

Learn More

Address

1025 Connecticut Avenue, NW
Suite 1000
Washington, DC 20036
(202) 828-1226

Join Our Mailing List

    • About
    • Terms of Use
    • Contact Us
    • Support

    Copyright © American Antitrust Institute 2022